| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | -1.39% | -0.68% | -0.71% | -0.71% | — |
| 14d | 2 | +50.00% | -3.12% | +1.33% | -4.45% | -4.45% | — |
| 30d | 2 | +0.00% | +3.50% | +2.00% | +1.50% | +1.50% | — |
| 60d | 2 | +100.00% | -9.99% | +0.59% | -10.58% | -10.58% | — |
| 90d | 2(1 pending) | +0.00% | +13.19% | -1.11% | +14.29% | +14.29% | — |
| 180d | 2(2 pending) | — | — | — | — | — | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TCRX TSCAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 67,000 | — | — | 67,000 | May 20, 2026 | May 22, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE Chief Operating Officer | 10,220 | $49.57 | $506.7K | 620,055 | Apr 16, 2026 | Apr 20, 2026 ↗ | View → |
| NGNE NEUROGENE INC. | PURCHASEGRANT Stock grant | 12,050 | — | — | 12,050 | Feb 20, 2026 | Feb 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 47,021 | — | — | 630,275 | Feb 9, 2026 | Feb 11, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE Chief Operating Officer | 16,746 | $42.70 | $715.1K | 583,254 | Jan 13, 2026 | Jan 15, 2026 ↗ | View → |
| TCRX TSCAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 67,000 | — | — | 67,000 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| NGNE NEUROGENE INC. | PURCHASEGRANT Stock grant | 12,050 | — | — | 12,050 | Jun 12, 2025 | Jun 16, 2026 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 1,500 | — | — | 6,000 | Jun 9, 2025 | Jun 10, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 110,067 | — | — | 110,067 | May 2, 2025 | May 6, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Apr 27, 2025 | Apr 29, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 500,000 | — | — | 600,000 | Apr 27, 2025 | Apr 29, 2025 ↗ | View → |
| NGNE NEUROGENE INC. | PURCHASEGRANT Stock grant | 7,700 | — | — | 7,700 | Jun 14, 2024 | Jun 16, 2026 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 23,944 | — | — | 23,944 | Jun 13, 2024 | Jun 20, 2024 ↗ | View → |
| TCRX TSCAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 47,500 | — | — | 47,500 | Jun 12, 2024 | Jun 14, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 45,000 | — | — | 135,000 | Jun 10, 2024 | Jun 11, 2024 ↗ | View → |
| NGNE NEUROGENE INC. | PURCHASEGRANT Stock grant | 15,400 | — | — | 15,400 | Jan 16, 2024 | Jun 15, 2026 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 11,960 | — | — | 11,960 | Dec 7, 2023 | Dec 12, 2023 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 20,522 | — | — | 20,522 | Dec 7, 2023 | Dec 12, 2023 ↗ | View → |
| TCRX TSCAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,500 | — | — | 17,500 | Dec 6, 2023 | Dec 8, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Oct 16, 2023 | Oct 18, 2023 ↗ | View → |